Gene expression profiling of hepatitis B- and hepatitis C-related hepatocellular carcinoma using graphical Gaussian modeling

Genomics

Volumn 101, Issue 4, 2013, Pages 238-248

  Ueda, Teruyuki ^a   Honda, Masao ^a   Horimoto, Katsuhisa ^b   Aburatani, Sachiyo ^b   Saito, Shigeru ^b   Yamashita, Taro ^a   Sakai, Yoshio ^a   Nakamura, Mikiko ^a   Takatori, Hajime ^a   Sunagozaka, Hajime ^a   Kaneko, Shuichi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

Author keywords

Gene expression; Hepatitis B virus; Hepatitis C virus; Hepatocellular carcinoma

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; STAT1 PROTEIN; TRANSCRIPTION FACTOR AP 1; VASCULOTROPIN;

ARTICLE; CANCER SUSCEPTIBILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE CLUSTER; GENE EXPRESSION PROFILING; GRAPHICAL GAUSSIAN MODEL; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MATHEMATICAL MODEL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; UPREGULATION;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CELL ADHESION; DNA DAMAGE; EARLY GROWTH RESPONSE PROTEIN 1; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MODELS, GENETIC; NORMAL DISTRIBUTION; STAT1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC; VASCULAR ENDOTHELIAL GROWTH FACTORS; WNT SIGNALING PATHWAY;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 84875504876     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2013.02.007     Document Type: Article

References (53)

1. Siegel R., Naishadham D., Jemal A. Cancer statistics, 2012. CA Cancer J. Clin. 2012, 62:10-29.
2. Tsukuma H., Hiyama T., Tanaka S., Nakao M., Yabuuchi T., Kitamura T., Nakanishi K., Fujimoto I., Inoue A., Yamazaki H. Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N. Engl. J. Med. 1993, 328:1797-1801.
3. Arzumanyan A., Reis H.M., Feitelson M.A. Pathogenic mechanisms in HBV- and HCV-associated hepatocellular carcinoma. Nat. Rev. Cancer 2012, 13:123-135.
4. Yoshida H., Shiratori Y., Moriyama M., Arakawa Y., Ide T., Sata M., Inoue O., Yano M., Tanaka M., Fujiyama S., Nishiguchi S., Kuroki T., Imazeki F., Yokosuka O., Kinoyama S., Yamada G., Omata M. Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of hepatocarcinogenesis by interferon therapy. Ann. Intern. Med. 1999, 131:174-181.
5. Fattovich G., Stroffolini T., Zagni I., Donato F. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 2004, 127:S35-S50.
6. de La Coste A., Romagnolo B., Billuart P., Renard C.A., Buendia M.A., Soubrane O., Fabre M., Chelly J., Beldjord C., Kahn A., Perret C. Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:8847-8851.
7. Calvisi D.F., Ladu S., Gorden A., Farina M., Conner E.A., Lee J.S., Factor V.M., Thorgeirsson S.S. Ubiquitous activation of Ras and Jak/Stat pathways in human HCC. Gastroenterology 2006, 130:1117-1128.
8. Thoresen G.H., Guren T.K., Sandnes D., Peak M., Agius L., Christoffersen T. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis. J. Cell. Physiol. 1998, 175:10-18.
9. Honda M., Kaneko S., Kawai H., Shirota Y., Kobayashi K. Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology 2001, 120:955-966.
10. Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., Kaneko S. Different signaling pathways in the livers of patients with chronic hepatitis B or chronic hepatitis C. Hepatology 2006, 44:1122-1138.
11. Honda M., Nakamura M., Tateno M., Sakai A., Shimakami T., Shirasaki T., Yamashita T., Arai K., Yamashita T., Sakai Y., Kaneko S. Differential interferon signaling in liver lobule and portal area cells under treatment for chronic hepatitis C. J. Hepatol. 2010, 53:817-826.
12. Kishino H., Waddell P.J. Correspondence analysis of genes and tissue types and finding genetic links from microarray data. Genome Inform. Ser. Workshop Genome Inform. 2000, 11:83-95.
13. Waddell P.J., Kishino H. Cluster inference methods and graphical models evaluated on NCI60 microarray gene expression data. Genome Inform. Ser. Workshop Genome Inform. 2000, 11:129-140.
14. Krumsiek J., Suhre K., Illig T., Adamski J., Theis F.J. Gaussian graphical modeling reconstructs pathway reactions from high-throughput metabolomics data. BMC Syst. Biol. 2011, 5:21.
15. Toh H., Horimoto K. Inference of a genetic network by a combined approach of cluster analysis and graphical Gaussian modeling. Bioinformatics 2002, 18:287-297.
16. Aburatani S., Sun F., Saito S., Honda M., Kaneko S., Horimoto K. Gene systems network inferred from expression profiles in hepatocellular carcinogenesis by graphical Gaussian model. EURASIP J. Bioinform. Syst. Biol. 2007, 47214.
17. Huang da W., Sherman B.T., Tan Q., Kir J., Liu D., Bryant D., Guo Y., Stephens R., Baseler M.W., Lane H.C., Lempicki R.A. DAVID bioinformatics resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res. 2007, 35:W169-W175.
18. Russell L., Forsdyke D.R. A human putative lymphocyte G0/G1 switch gene containing a CpG-rich island encodes a small basic protein with the potential to be phosphorylated. DNA Cell Biol. 1991, 10:581-591.
19. Zhong L., Ou J., Barkai U., Mao J.F., Frasor J., Gibori G. Molecular cloning and characterization of the rat ovarian 20 alpha-hydroxysteroid dehydrogenase gene. Biochem. Biophys. Res. Commun. 1998, 249:797-803.
20. Mani K.M., Lefebvre C., Wang K., Lim W.K., Basso K., Dalla-Favera R., Califano A. A systems biology approach to prediction of oncogenes and molecular perturbation targets in B-cell lymphomas. Mol. Syst. Biol. 2008, 4:169.
21. Kwon H.K., Hwang J.S., So J.S., Lee C.G., Sahoo A., Ryu J.H., Jeon W.K., Ko B.S., Im C.R., Lee S.H., Park Z.Y., Im S.H. Cinnamon extract induces tumor cell death through inhibition of NFkappaB and AP1. BMC Cancer 2010, 10:392.
22. Mitchell K.R., Warshawsky D. Xenobiotic inducible regions of the human arylamine N-acetyltransferase 1 and 2 genes. Toxicol. Lett. 2003, 139:11-23.
23. Bottomly D., Kyler S.L., McWeeney S.K., Yochum G.S. Identification of {beta}-catenin binding regions in colon cancer cells using ChIP-Seq. Nucleic Acids Res. 2010, 38:5735-5745.
24. Ingram J.L., Antao-Menezes A., Mangum J.B., Lyght O., Lee P.J., Elias J.A., Bonner J.C. Opposing actions of Stat1 and Stat6 on IL-13-induced up-regulation of early growth response-1 and platelet-derived growth factor ligands in pulmonary fibroblasts. J. Immunol. 2006, 177:4141-4148.
25. Liao H., Hyman M.C., Lawrence D.A., Pinsky D.J. Molecular regulation of the PAI-1 gene by hypoxia: contributions of Egr-1, HIF-1alpha, and C/EBPalpha. FASEB J. 2007, 21:935-949.
26. Lejard V., Blais F., Guerquin M.J., Bonnet A., Bonnin M.A., Havis E., Malbouyres M., Bidaud C.B., Maro G., Gilardi-Hebenstreit P., Rossert J., Ruggiero F., Duprez D. EGR1 and EGR2 involvement in vertebrate tendon differentiation. J. Biol. Chem. 2011, 286:5855-5867.
27. Golubovskaya V., Kaur A., Cance W. Cloning and characterization of the promoter region of human focal adhesion kinase gene: nuclear factor kappa B and p53 binding sites. Biochim. Biophys. Acta 2004, 1678:111-125.
28. Berasi S.P., Huard C., Li D., Shih H.H., Sun Y., Zhong W., Paulsen J.E., Brown E.L., Gimeno R.E., Martinez R.V. Inhibition of gluconeogenesis through transcriptional activation of EGR1 and DUSP4 by AMP-activated kinase. J. Biol. Chem. 2006, 281:27167-27177.
29. Gu J., Tamura M., Pankov R., Danen E.H., Takino T., Matsumoto K., Yamada K.M. Shc and FAK differentially regulate cell motility and directionality modulated by PTEN. J. Cell Biol. 1999, 146:389-403.
30. Rual J.F., Venkatesan K., Hao T., Hirozane-Kishikawa T., Dricot A., Li N., Berriz G.F., Gibbons F.D., Dreze M., Ayivi-Guedehoussou N., Klitgord N., Simon C., Boxem M., Milstein S., Rosenberg J., Goldberg D.S., Zhang L.V., Wong S.L., Franklin G., Li S., Albala J.S., Lim J., Fraughton C., Llamosas E., Cevik S., Bex C., Lamesch P., Sikorski R.S., Vandenhaute J., Zoghbi H.Y., Smolyar A., Bosak S., Sequerra R., Doucette-Stamm L., Cusick M.E., Hill D.E., Roth F.P., Vidal M. Towards a proteome-scale map of the human protein-protein interaction network. Nature 2005, 437:1173-1178.
31. Hecker T.P., Grammer J.R., Gillespie G.Y., Stewart J., Gladson C.L. Focal adhesion kinase enhances signaling through the Shc/extracellular signal-regulated kinase pathway in anaplastic astrocytoma tumor biopsy samples. Cancer Res. 2002, 62:2699-2707.
32. Okabe H., Satoh S., Kato T., Kitahara O., Yanagawa R., Yamaoka Y., Tsunoda T., Furukawa Y., Nakamura Y. Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res. 2001, 61:2129-2137.
33. Hippo Y., Watanabe K., Watanabe A., Midorikawa Y., Yamamoto S., Ihara S., Tokita S., Iwanari H., Ito Y., Nakano K., Nezu J., Tsunoda H., Yoshino T., Ohizumi I., Tsuchiya M., Ohnishi S., Makuuchi M., Hamakubo T., Kodama T., Aburatani H. Identification of soluble NH2-terminal fragment of glypican-3 as a serological marker for early-stage hepatocellular carcinoma. Cancer Res. 2004, 64:2418-2423.
34. Shirota Y., Kaneko S., Honda M., Kawai H.F., Kobayashi K. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 2001, 33:832-840.
35. Hoshida Y., Villanueva A., Kobayashi M., Peix J., Chiang D.Y., Camargo A., Gupta S., Moore J., Wrobel M.J., Lerner J., Reich M., Chan J.A., Glickman J.N., Ikeda K., Hashimoto M., Watanabe G., Daidone M.G., Roayaie S., Schwartz M., Thung S., Salvesen H.B., Gabriel S., Mazzaferro V., Bruix J., Friedman S.L., Kumada H., Llovet J.M., Golub T.R. Gene expression in fixed tissues and outcome in hepatocellular carcinoma. N. Engl. J. Med. 2008, 359:1995-2004.
36. Xia L., Huang W., Tian D., Zhu H., Zhang Y., Hu H., Fan D., Nie Y., Wu K. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma. J. Hepatol. 2012, 57:600-612.
37. Ura S., Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., Sunakozaka H., Sakai Y., Horimoto K., Kaneko S. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009, 49:1098-1112.
38. Turner R., Lozoya O., Wang Y., Cardinale V., Gaudio E., Alpini G., Mendel G., Wauthier E., Barbier C., Alvaro D., Reid L.M. Human hepatic stem cell and maturational liver lineage biology. Hepatology 2011, 53:1035-1045.
39. Sze K.M., Chu G.K., Lee J.M., Ng I.O. C-terminal truncated HBx is associated with metastasis and enhances invasiveness via C-Jun / MMP10 activation in hepatocellular carcinoma. Hepatology 2012.
40. Tanaka Y., Kanai F., Ichimura T., Tateishi K., Asaoka Y., Guleng B., Jazag A., Ohta M., Imamura J., Ikenoue T., Ijichi H., Kawabe T., Isobe T., Omata M. The hepatitis B virus X protein enhances AP-1 activation through interaction with Jab1. Oncogene 2006, 25:633-642.
41. Sung W.K., Zheng H., Li S., Chen R., Liu X., Li Y., Lee N.P., Lee W.H., Ariyaratne P.N., Tennakoon C., Mulawadi F.H., Wong K.F., Liu A.M., Poon R.T., Fan S.T., Chan K.L., Gong Z., Hu Y., Lin Z., Wang G., Zhang Q., Barber T.D., Chou W.C., Aggarwal A., Hao K., Zhou W., Zhang C., Hardwick J., Buser C., Xu J., Kan Z., Dai H., Mao M., Reinhard C., Wang J., Luk J.M. Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat. Genet. 2012, 44:765-769.
42. Oishi N., Shilagardi K., Nakamoto Y., Honda M., Kaneko S., Murakami S. Hepatitis B virus X protein overcomes oncogenic RAS-induced senescence in human immortalized cells. Cancer Sci. 2007, 98:1540-1548.
43. Ortega-Molina A., Serrano M. PTEN in cancer, metabolism, and aging. Trends Endocrinol. Metab. 2012.
44. Liao Y., Shikapwashya O.N., Shteyer E., Dieckgraefe B.K., Hruz P.W., Rudnick D.A. Delayed hepatocellular mitotic progression and impaired liver regeneration in early growth response-1-deficient mice. J. Biol. Chem. 2004, 279:43107-43116.
45. Zwang Y., Sas-Chen A., Drier Y., Shay T., Avraham R., Lauriola M., Shema E., Lidor-Nili E., Jacob-Hirsch J., Amariglio N., Lu Y., Mills G.B., Rechavi G., Oren M., Domany E., Yarden Y. Two phases of mitogenic signaling unveil roles for p53 and EGR1 in elimination of inconsistent growth signals. Mol. Cell 2011, 42:524-535.
46. Yu J., Zhang S.S., Saito K., Williams S., Arimura Y., Ma Y., Ke Y., Baron V., Mercola D., Feng G.S., Adamson E., Mustelin T. PTEN regulation by Akt-EGR1-ARF-PTEN axis. EMBO J. 2009, 28:21-33.
47. Lu D., Han C., Wu T. Microsomal prostaglandin E synthase-1 promotes hepatocarcinogenesis through activation of a novel EGR1/beta-catenin signaling axis. Oncogene 2012, 31:842-857.
48. Chung T.W., Lee Y.C., Ko J.H., Kim C.H. Hepatitis B Virus X protein modulates the expression of PTEN by inhibiting the function of p53, a transcriptional activator in liver cells. Cancer Res. 2003, 63:3453-3458.
49. Hettinger K., Vikhanskaya F., Poh M.K., Lee M.K., de Belle I., Zhang J.T., Reddy S.A., Sabapathy K. c-Jun promotes cellular survival by suppression of PTEN. Cell Death Differ. 2007, 14:218-229.
50. Chew V., Tow C., Teo M., Wong H.L., Chan J., Gehring A., Loh M., Bolze A., Quek R., Lee V.K., Lee K.H., Abastado J.P., Toh H.C., Nardin A. Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients. J. Hepatol. 2010, 52:370-379.
51. Chew V., Chen J., Lee D., Loh E., Lee J., Lim K.H., Weber A., Slankamenac K., Poon R.T., Yang H., Ooi L.L., Toh H.C., Heikenwalder M., Ng I.O., Nardin A., Abastado J.P. Chemokine-driven lymphocyte infiltration: an early intratumoural event determining long-term survival in resectable hepatocellular carcinoma. Gut 2012, 61:427-438.
52. Freund R.J., Wilson W.J. Regression analysis : statistical modeling of a response variable 1998, Academic Press, San Diego.
53. Aburatani S., Goto K., Saito S., Toh H., Horimoto K. ASIAN: a web server for inferring a regulatory network framework from gene expression profiles. Nucleic Acids Res. 2005, 33:W659-W664.